mmCSM-AB: guiding rational antibody engineering through multiple point mutations. (2020)
Attributed to:
Newton001 Understanding Antimicrobial Resistance Mutations in Tuberculosis: Towards Personalised Treatment to Combat Multi-drug Resistance
funded by
Newton Fund
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/nar/gkaa389
PubMed Identifier: 32432715
Publication URI: http://europepmc.org/abstract/MED/32432715
Type: Journal Article/Review
Volume: 48
Parent Publication: Nucleic acids research
Issue: W1
ISSN: 0305-1048